PKM and cancer: Even though it is widely assumed that PKM2 acts as a bottleneck in metabolite flux through glycolysis in cancer cells [146], this view is challenged by some reports, showing that PKM2 activity is not limiting for metabolite flux in cancer cells [57,147], and it is even dispensable for cancer cells [148].